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Transmission of mitogenic and developmental signals to
intracellular targets is often mediated by inositol
derivatives. Here we present the cloning and character-
ization of a gene from Saccharomyces cerevisiae, PIK],
encoding the enzyme that catalyses the first committed
step in the production of the second messenger inositol-
1,4,5-trisphosphate. PIKI encodes a phosphatidylinositol
4-kinase (PI 4-kinase) essential for growth. Cells carrying
PIKI on a multicopy vector overexpress PI 4-kinase
activity exclusively in a nuclear fraction, suggesting that
PIK1 is part of a nuclear phosphoinositide cycle.
Temperature-sensitive mutations, but not a null
mutation, can be suppressed by high osmolarity or an
elevated concentration of Ca2+. Conditional mutants
have a cytokinesis defect as indicated by a uniform
terminal phenotype of cells with large buds and fully
divided nuclei. We suggest that PIK1 controls cytokinesis
through the actin cytoskeleton.
Key words: actin/cytokinesis/nucleus/PI 4-kinase/signal
transduction/S. cerevisiae
Introduction
Stimulation of a variety of receptors at the cell surface can
activate either one of two different signalling pathways that
use phosphatidylinositol (PI) derivatives as messengers. One
pathway involves PI 3-kinase which phosphorylates position
3 of the inositol ring [see Downes and MacPhee (1990) and
Cantley et al. (1991) for reviews]. In mammalian cells, PI
3-kinase is thought to mediate the transmission of the
oncogenic or mitogenic signal of receptor or non-receptor
tyrosine kinases (Cantley et al., 1991; Valius and
Kazlauskas, 1993). A PI 3-kinase and two homologues have
also been detected in yeast cells, where they have been
implicated in the control of membrane traffic (Herman et al.,
1992) and proposed to play a role in cell cycle regulation,
respectively (Kunz et al., 1993; Helliwell et al., 1994). A
second and better characterized signal transduction pathway
involves the activation of a phosphoinositide-specific
phospholipase C (see reviews cited above) which hydrolyses
phosphatidylinositol-4,5-bisphosphate (PI-4,5-P2) to
produce diacylglycerol (DAG) and inositol-1,4,5-trisphos-
phate (1P3). DAG activates protein kinase C (PKC) which
in turn phosphorylates and activates a number of other
protein kinases and transcription factors, leading to cell
proliferation [reviewed in Nishizuka (1988)]. PKC could
phosphorylate transcription factors in the cytoplasm and these
could be subsequently translocated into the nucleus.
Alternatively, PKC itself could be translocated into the
nucleus as part of the activation process. There is some
evidence for the latter possibility in ras-transformed cells
(Chiarugi et al., 1990) and in fibroblasts treated with growth
factors (Divecha et al., 1991). A wholly nuclear
phosphoinositide signalling system has been proposed(Divecha et al., 1993), based on the detection of many of
the enzymes involved in phosphoinositide metabolism in
isolated rat nuclear envelopes and in demembranated
mammalian nuclei (Smith and Wells, 1983; Payrastre et al.,
1992). The other product of phospholipase C, IP3, binds to
specific receptors and induces the release of Ca2+ ions from
intracellular stores, thus regulating the Ca2+/calmodulin-
dependent protein kinases and phosphatases and promoting
cell division in synergy with the DAG signal [reviewed in
Berridge and Irvine (1989) and Whitman and Cantley
(1988)]. IP3 receptors are found mainly in the nuclear
envelope and the endoplasmic reticulum proximal to the
nucleus (Ross et al., 1989), and IP3 seems to have an
essential role in nuclear envelope assembly (Sullivan et al.,
1993). Another inositol phosphate, inositol-1,4-bisphosphate
(1P2), possibly produced by dephosphorylation of IP3, also
has a nuclear role in activating DNA polymerase a, perhaps
to initiate the S phase of the cell cycle (Sylvia et al., 1988).
A DAG/IP3 signalling pathway in yeast cells may play a
role in the control of the cell cycle (Hawkins et al., 1993
and references therein).
The first phosphorylation of the PI inositol ring in the
pathway leading to IP2 and IP3 is accomplished by PI
4-kinase. This enzymatic activity has been described in
vertebrates and yeast (Buxeda et al., 1991; Flanagan and
Thorner, 1992; Nickels et al., 1992; McKenzie and Carman,
1993) and all, except one of the at least three yeast activities,
have been found to be membrane-associated (Flanagan and
Thorner, 1992). PI 4-kinase is also one of the
phosphoinositide cycle enzymes described to have a nuclear
form. More specifically, it has been claimed to be part of
the nuclear pore- lamina fraction of hepatocytes and
NIH3T3 cells (Payrastre et al., 1992).
We have searched for components of the yeast nuclear
pore complex with antibodies raised against nuclear
envelopes. One such antibody was the monoclonal antibody
QE5 that recognizes hNUP153, a component of the nuclear
pore complex of HeLa cells (McMorrow et al., 1994). In
preparations of Xenopus nuclear envelopes, this antibody
immunodecorates intranuclear structures of the pore complex
(Pante and Aebi, 1993). In the present work, we use this
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antibody to clone a yeast gene encoding an essential, nuclear
PI 4-kinase (ATP:phosphatidylinositol 4-phosphotransferase,
EC 2.7.1.67), which we have termed PIK] (phospha-
tidylinositol kinase).
Protein Western
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Results
Isolation of the essential PIK1 gene
Membrane blots containing total yeast proteins were probed
with the anti-human nucleoporin monoclonal antibody QE5
(McMorrow et al., 1994). The antibody recognized
predominantly a protein of - 102 kDa. This protein was
recovered quantitatively in a highly purified preparation of
yeast nuclei, as evidenced by probing blots containing cell-
equivalent amounts of protein from a total cell homogenate,
a cytosolic fraction and purified nuclei (Figure 1).
The antibody was used to screen a Xgtl 1 genomic yeast
expression library and the - 500 bp insert from a positive
phage was subcloned into the integrative shuttle vector
YIplac2 11. Sequencing of the cloned DNA revealed that it
was a previously undescribed sequence. A preliminary
genomic disruption of the cloned sequence by targeted
integration of the plasmid cut at a Bgll site in the insert
indicated that the cloned sequence was an internal segment
of an essential gene. The gene was subsequently named PIK]
(see below and Introduction). To obtain the complete gene,
the cloned DNA fragment was used as a probe to screen
a yeast genomic library constructed in the high copy number
vector pSEY 18. A positive clone containing a 15 kbp insert
(pGBl) was identified which also overexpressed the antigen
recognized by the QE5 monoclonal (Figure 2), suggesting
that the genomic clone was a full-length clone encoding the
yeast protein recognized by the antibody. Based on three
independent measurements by densitometry on Western
blots, the antigen was overexpressed 2.5- to 4-fold in strains
containing pGB1.
To determine the location ofPIK] within the 15 kbp insert
of pGBl, restriction digests of pGB1 were probed with the
original - 500 bp fragment. The region corresponding to
the - 500 bp fragment mapped to a position within the insert
designated as X in Figure 3A. Knowing the location ofPIK]
within the 15 kbp genomic insert, a second gene disruption
was constructed by substituting a Bgll fragment containing
the ADE2 gene (Stoz and Linder, 1990) for the 1.2 kbp Bglll
fragment present in the insert (Figure 3B). This construct
was used to transform diploid strain JK9-3da/a ade2A/ade2A
to generate strain FM1 (JK9-3da/a pikl]::ADE2-1/PIK1
ade2A/ade2A). The disruption was confirmed by Southern
blotting (data not shown). When strain FM1 was sporulated
and dissected, only two spores from each of the > 30 tetrads
analysed survived and formed colonies, all of them ade-.
Microscopic examination of the spores that did not form
colonies revealed that they either did not germinate or
germinated but arrested before completing cytokinesis. This
further demonstrated that PIKI is a unique gene essential
for growth.
The boundaries of PIK] within the cloned fragment
(Figure 3A) were determined by testing the ability of
different subclones to complement the lethality of the
disruption in strain FM1. The smallest subclone tested
(pGB3) that complemented the PIK] disruption was the 4.1
kbp SphI-SacI fragment shown in Figure 3B. Cells
containing pGB3 also overproduced the 102 kDa antigen
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Fig. 1. Recognition of yeast proteins by the QE5 monoclonal antibody.
A yeast homogenate (H) was fractionated into cytosolic (C) and
nuclear (N) fractions, separated on an 8% SDS-PAGE gel and
blotted on to a PVDF membrane. Cell-equivalent amounts of protein
from each fraction and the homogenate were loaded. The respective
amounts for homogenate, cytosol and nucleus were 68, 45 and 14 sg
of protein. The left panel (Protein) shows the membrane stained for
protein with amido black. The right panel (Western) shows the same
membrane probed with the QE5 monoclonal (uppermost). Shown
below are the signals obtained by probing with antibodies against the
plasma membrane protein GAS1 (Gaslp) (Nuoffer et al., 1991), the
cytoplasmic protein hexokinase (Hexokinase), and the nuclear protein
NSP1 (Nsplp) (Nehrbass et al., 1990). The sizes of the molecular
weight standards are indicated in kDa.
Western
1 2 3
- -, ."-O
Protein
1 2 3
v 200
W 116
97
....~~~~~~~~~~~ ~~~~~~~.........._ W
!
6
45
Fig. 2. Overexpression of the QE5 yeast antigen by strains containing
PIK] on a high copy number plasmid. Approximately 30 Ug of protein
from total homogenates of strain JK9-3d containing no plasmid (lane
1), pGBl (lane 2) and pGB3 ( lane 3) were separated in duplicate on
two halves of the same SDS-PAGE gel. One half of the gel was
stained with Coomassie blue (Protein) and the other half was blotted to
a membrane and probed with the QE5 monoclonal (Western). The
sizes of the molecular weight standards are indicated in kDa.
recognized by QE5 (Figure 2). Furthermore, using the
essential 1.2 kbp Bgll fragment contained within pGB3 as
a probe, it was observed that cells carrying pGB1
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Fig. 3. Restriction maps and disruption of PIK]. (A) Segment of the
insert from the original full-length clone pGBI. The boxed-in X
indicates the segment corresponding to the insert in the original Xgtl 1
clones. LYPI and PIKI ORFs are indicated by open arrows. (B)
Detail of the PIK] region and disruption. The open box marks the
region of highest homology to other PI kinases. Open arrow indicates
the PIKI ORF. Restriction sites are Ba, BamHI; Bg, Bgll; E, EcoRI;
H, Hindml; P, PstI; Sa, SacI; Sp, SphI; X, XhoI.
overexpressed an RNA that migrated slightly slower than
the yeast 3.4 kb rRNA (data not shown), indicating that the
mRNA encoded by PIK] was between 3.5 and 4.0 kb in
size. An mRNA of this size would normally encode a protein
> 102 kDa, but 10-20% discrepancies between calculated
and observed sizes in SDS gels are not unusual. The size
discrepancy between the coding capacity of the mRNA and
the observed 102 kDa protein could also be accounted for
by proteolysis.
Nucleotide sequence and genomic location of PIK1
The complete nucleotide sequence of both strands of the
minimal complementing fragment, the 4.1 kbp SphI-SacI
fragment (Figure 3B), was determined. A single ORF of
>300 bp was found. In agreement with the previously
detected 3.5-4.0 kb RNA, the PIK] ORF is 3198 bp in
length. In addition, it includes the sequence previously found
in the Xgtl 1 clone, has a GC content of 38% and is flanked
by known yeast promoter elements on the 5' side and by
putative polyadenylation signals (Wahle and Keller, 1992)
on the 3' side (Figure 4). Sequence information obtained
from outside the SphI-SacI fragment revealed that the LYPI
gene (Sychrova and Chevalier, 1993) ends 493 bp upstream
of PIK]. Between LYP] and PIK] there are several sequence
motifs with strong homology to known yeast promoter
elements. Of several putative TATA boxes, one at -102
from the ATG codon is optimally located (Hahn et al., 1985;
Rudolph and Hinnen, 1987). Additionally, there are three
pheromone response elements (PRE) (Kronstad et al., 1987)
at -441 (inverted, one mismatch), -348 (inverted, one
mismatch) and -195 (direct, no mismatches). There are also
two SWI4-SWI6 cell cycle boxes (SCB) (Koch et al., 1993)
located between the two gene-proximal PREs, at -236
(direct, one mismatch) and -212 (inverted, no mismatches).
A functional SCB has been shown to promote transcription
in the late GI phase of the cell cycle (Breeden and
Nasmyth, 1987; Koch et al., 1993). Also intriguingly present
are the three conserved elements of yeast splicing signals
(Langford et al., 1984); the 5' splice site at -351, the
internal consensus sequence at +333 and the 3' splice site
at +382. We consider it unlikely that these signals are
functional, however, because the theoretical 5' splice site
at -351 probably lies outside the transcribed region.
Furthermore, no significant amount of the predicted spliced
product was found by Northern blotting.
The genomic location of PIK] was investigated by probing
blots of separated Saccharomyces cerevisiae chromosomes
with the 1.2 kbp Bgtl fragment described above (Figure 3B).
A single band corresponding to chromosome XIV was
obtained. To localize the gene more precisely within
chromosome XIV, the same probe was hybridized to filters
containing a set of ordered X and cosmid clones of the yeast
genome (Riles et al., 1993). The probe hybridized to clones
corresponding to a position - 140 kbp from the left telomere
of chromosome XIV, between MET2 and RAD50.
PIK1 is homologous to Pi kinases
Translation of the PIK] ORF yielded a protein of 119 922
Da with a calculated pI of 6.46. As discussed above, we
do not know at present the reason for the discrepancy
between this theoretical molecular weight and the observed
size of 102 kDa in Western blots (Figure 1). The amino acid
composition is rich in leucine and serine and has a ratio of
charged to apolar residues of 0.9, suggesting that the protein
is not globular (Cohen and Parry, 1986). There are no
obvious secretory signal sequences or transmembrane
domains but there is a conspicuous 25 amino acid acidic
stretch (amino acids 335 -361) with a net charge of -12
that has some resemblance to the Zn2+ binding site of
parathymosin (Brand et al., 1988). The presence of a metal
binding site would be congruent with the requirement for
divalent cations to stabilize the nuclear pore structures
recognized by the QE5 monoclonal (Jarnik and Aebi, 1991;
Pante and Aebi, 1993). Other features of the deduced
sequence are a putative nuclear localization signal K491KGK
in a typical context of close proline residues and a casein
kinase II site (reviewed in Garcia-Bustos et al., 199 la),
suggesting that the protein can be translocated into the
nucleus.
A search for sequence homologies using the BLAST and
FASTA programs (see Materials and methods) revealed a
lipid kinase sequence motif at the carboxy-terminus of PIK1
(amino acids 794-950). This motif is also found at the
carboxy-terminus of all other proteins known or presumed
to be PI kinases (Figure 5) and is supposedly part of the
lipid kinase active site (Hiles et al., 1992; Kunz et al., 1993;
Schu et al., 1993; Helliwell et al., 1994).
PIK1 is a Pi 4-kinase associated with the nucleus
Because PIK1 contains a lipid kinase motif, we investigated
whether it has PI kinase activity. We examined whether a
strain (BJ2168/pGB1) containing PIKI on a high copy
number plasmid overexpressed PI kinase activity; as
mentioned above, strains containing pGB1 were previously
shown to overexpress an antigen recognized by the
monoclonal antibody QE5. The reaction products obtained
by incubating total cell homogenates (data not shown) and
subcellular fractions with PI and [32P]ATP were assayed by
thin layer chromatography (TLC) and autoradiography (see
Materials and methods). Total cell homogenates displayed
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- 4 78 GCATGCCTTCAAAATAGAAAAAAATAAAAAAATAGACGTTTCATTAATCAAAATAGCCTGTAGAGATTTTGAGGGATTGCCCCAAACTTTATGTATAATA -37 9
-3 78 TCACCACTTATTATTCACTATTCATAGTATGTTACATCATAAGGCCATTGTCACCTTCGGCCAGCGATAGTACTCAAATCTATAATAAATTTTCCATATT -279
-278 ATCCTTTACGTACTTGATAGCGTGTATAACAGGGTCATTATTCACGATATGTTCAACTGTTGTCATTTTCGTGTTATTGCACTGAAACAAAAGAACCCTA -179
-1768 CCAAAAAATTCGTTAGAGAAAAACTAAAAGTACAAGATCTTATACTGAAGACCCTTCATTTTTTAGGCCCAACTTCTATTAGAAGATCCCTGGACCC -79
-78 TGCTAGAAATTTTCAATTAGCTTATCATTTTTCTTCATTGCGAGCGTTCGTTTTCATTAAGCATTCGTTCTCTTCACTATGCATAAAGCATC2CAGTTCM22
M H K A S S S K 8
23 AGAAAAGCTTTGATGATACTATTGAACTAAAAAATGAACAATTACTGMACTGATCAACTCTAGTGAATTCACCCTTCACAATTGTGTGGAGTTACT 122
9 K S F D D T I E L K K N E Q L L K L I N S S E F T L H N C V E L L 41
123 GTGCAAACACTCCGAAAATATTGGTATACATTACTATTTATGTCAGAAATTGGCCACATTTCCTCACAGCGAACTACAGTTCTATATTCCCCAACTAGTA 222
42 C K H S E N I G I H Y Y L C Q K L A T F P H S E L Q F Y I P Q L V 74
223 CAGGTCCTCGTCACCATGGAGACAGAATCAATGGCTTTAGAAGATTTACTATTAAGGTTGAGGGCGGAAAACCCTCATTTTGCACTACTGACGTTTTGGC 322
75 0 V L V T M E T E S M A L E D L L L R L R A E N P H F A L L T F N Q 108
323 AGTTACAAGCGTTACTAACGGATTTATCTACTGACCCCGCTTCTTATGGCTTCCAAGTGGCTAGAAGAGTCTTAAACAACTTACAAACCAATCTCTTTAA 422
109 L 0 A L L T D L S T D P A S Y G F Q V A R R V L N N L Q T N L F N 141
423 CACAAGTTCAGGTAGCGATAAAAATGTTAAAATACATGAAAACGTTGCACCGGCCTTAGTTCTTTCCTCTATGATAATGTCGGCTATAGCATTCCCCCAA 522
142 T S S G S D K N V K I H E N V A P A L V L S S M I M S A I A F P Q 174
523 TTAAGCGAAGTGACCAAACCATTAGTGGAATCTCAAGGTAGAAGACAAAAAGCTTTCGTTTTTAAGTTGGCTAGAAGTGCAATGAAAGATTTTACCAAGA 622
175 L S E V T K P L V E S 0 G R R 0 K A F V F K L A R S A M K D F T K N 208
623 ACATGACCTTGAAAAATACCCTACTAAACAAGAAAACTTCCAGATCCAAAAGAGTTAGCTCAAATCGCAGTTCAACTCCGACTTCTCCAATAGATTTAAT 722
209 M T L K N T L L N K K T S R S K R V S S N R S S T P T S P I D L I 241
723 AGATCCAATAAAAACTAAAGAAGATGCATCCTTCAGGAAATCCAGACATAGTGAGGTAAAATTGGATTTCGACATTGTGGATGATATAGGTAACCAGGTC 822
242 D P I K T K E D A S F R K S R H S E V K L D F D I V D D I G N 0 V 274
823 TTTGAAGAAAGAATCTCATCTTCAATCAAACTCCCAAAACGTAAACCTAAGTATTTGGATAATTCATACGTTCATAGGACATATGATGGCMAAATATAA 922
275 F E E R I S S S I K L P K R K P K Y L D N S Y V H R T Y D G K N I N 308
923 ACAGGGACGGAAGCATTTCAAATACCGCAAAGGCTCTCGATGGAAATAAAGGTGATTATATTTCTCCAAAGGGACGTAATGATGAAAATAATGAGATTGG 1022
309 R D G S I S N T A K A L D G N K G D Y I S P K G R N D E N H E I G 341
1023 TAACAATGAAGATGAAACTGGTGGTGAACGGAGGAGGACGCGGACGCTTTAAACTCTGATCACTTCACCAGTTCTATGCCAGATCTGCATAATATTCAA 1122
342 N N E D E T G G E T E E D A D A L N S D H F T S S M P D L H N I 0 374
1123 CCAAGGACTTCTTCTGCTTCATCTGCTTCTTTAGMGGGACACCTAAGTTAAACAGGACCAATTCCCAACCCCTTTCGCGCCAGGCATTCAAAAACAGTA 1222
375 P R T S S A S S A S L E G T P K L N R T N S Q P L S R Q A F K N S K 408
1223 AAAAAGCGAATTCTTCTTTGAGTCAAGAAATTGACTTGTCGCAATTATCGACCACTTCAAAAATAAAAATGTTAAAAGCAAATTATTTTCGTTGCGAGAC 1322
409 K A N S S L S 0 E I D L S 0 L S T T S K I K M L K A N Y F R C E T 441
1323 ACAATTTGCCATTGCGCTAGAAACAATATCTCAAAGGCTAGCTCGAGTACCGACAGAAGCTAGATTGAGTGCCTTACGAGCCGAGTTGTTTCTATTAAAC 1422
442 Q F A I A L E T I S 0 R L A R V P T E A R L S A L R A E L F L L N 474
1423 AGGGACCTACCAGCGGAAGTAGATATCCCCACTTTATTGCCTCCAAATAAAAAAGGAAAGTTACATAAATTAGTGACCATTACTGCTAATGAGGCACAAG 1522
475 R D L P A E V D I P T L L P P N K K G K L H K L V T I T A N E A 0 V 508
1523 TTTTGAACTCTGCAGAAAAAGTTCCATATTTACTCCTGATAGAATACTTGAGAGACGAATTTGATTTTGACCCAACAAGTGAAACCAATGAAAGATTATT 1622
509 L N S A E K V P Y L L L I E Y L R D E F D F D P T S E T N E R L L 541
1623 AAAGAAGATCAGTGGTAATCAGGGAGGCTTGATATTTGATTT12ATTACATGAATAGAAAAGAAAACAACGAAAATAGAAATG2AAGTACTCTTACTAGC1722
542 K K I S G N Q G G L I F D L N Y M N R K E N N E N R N E S T L T S 574
1723 AACAACACTCGATCTTCGGTATATGATAGTAACTCGTTCAACAACGGGGCCTCCCGCAATGAAGGTCTATCCAGTACCTCAAGAAGTGATTCAGCGTCCA 1822
575 N N T R S S V Y D S N S F N N G A S R N E G L S S T S R S D S A S T 608
1823 CAGCTCATGTTAGGACTGAAGTCAATAAAGAGGAAGATTTAGGTGATATGTCAATGGTAAAAGTCAGGAACAGAACGGATGACGAAGCGTATAGAAATGC 1922
609 A H V R T E V N K E E D L G D M S M V K V R N R T D D E A Y R N A 641
1923 TTTAGTAATACAGAGTGCCGCAAATGTTCCAATTTTACCTGATGATAGTCAAGACAGAAGCCCAGAGTTGAACTTTGGCTCAAACTTGGACGAAGTACTC 2022
642 L V I 0 S A A N V P I L P D D S 0 D R S P E L N F G S N L D E V L 674
2023 ATCGAGAATGGAATTAATAGCAAAAATATACATAGCCAAACTGACGCTTTAGCAGACCAGATGAGAGTTTCAGCTGTTATGTTAGCACAATTGGATAAGT 2122
675 I E N G I N S K N I H S 0 T D A L A D 0 N R V S A V M L A 0 L D K S 708
2123 CGCCACAACAGTTATCAGAAAGTACCAAACAAATCCGCGCTCAAATTATTTCATCAATGAAGGAGGTGCAGGATAAATTTGGTTACCATGATTTGGAAGC 2222
709 P Q Q L S E S T K 0 I R A 0 I I S S M K E V Q D K F G Y H D L E A 741
2223 CCTTCATGGAATGGCAGGTGAGAGAAAATTGGAAAACGATTTAATGACGGGTGGTATTGACACTTCATATCTAGGTGAAGATTGGGCTACCAAGAAAGAG 2322
742 L H G M A G E R K L E N D L M T G G I D T S Y L G E D N A T K K E 774
2323 AGGATACGTAAAACTTCGGAATATGGCCATTTCGAAAACTGGGATTTATGTTCTGTAATCGCCAAGACGGGTGATGATTTGAGACAGGAGGCGTTTGCAT 2422
775 R I R K T S E Y G H F E N N D L C S V I A K T a n n TL R 0 A F A Y 808
2423 ACCAGATGATTCAAGCGATGGCCAATATTTGGGTTAAAGAAAAAGTTGACGTTTGGGTTAAAAGAATGAAAATTTTAATTACTAGTGCGAATACGGGACT 2522
809 0 M T 0 A M A N T V K K Kx v n V v K R M K _T T T T S A N T G T 841
2523 TGTGGAGACCATCACAAATGCTATGTCTGTGCATAGTATTAAAAAGGCTTTAACCAAAAAAATGATTGAAGATGCAGAACTAGATGACAAGGGTGGTATT 2622
842 V E T T T N A M S V H S T K K A L T K K N I E D A E L D D K G G I 874
2623 GCCTCTTTGAATGATCACTTCCTTAGAGCTTTTGGTAATCCTAATGGATTTAAGTATAGAAGAGCACAAGACAACTTTGCTTCTTCGTTAGCCGCATATT 2722
875 A S L N D H F L R A F G N P N G F K Y R R A Q D N F A S S AA S908
2723 CTGTCATTTGCTATCTCTTGCAGGTTAAAGATAGACACAACGGTAACATTATGATCGATAACGAAGGCCATGTAAGTCACATCGATTTTGGATTTATGCT 2822
909 V T C Y t L 0 V K n R N G N T M T n N K G H V S TD F G F M L 941
2823 ATCAAATTCACCCGGCTCAGTGGGCTTTGAGGCCGCACCATTCAAATTAACTTACGAATATATTGAACTGCTAGGCGGAGTAGAGGGAGAAGCGTTTAAA 2922
942 S N S P G S V G F e A A P F K L T Y E Y I E L L G G V E G E A F K 974
2923 AAGTTTGTTGAACTAACTAAAAGTTCGTTCAAGGCTCTGAGAAAGTATGCTGATCAAATCGTATCAATGTGTGAGATTATGCAAAAGGACAATATGCAGC 3022
975 K F V E L T K S S F K A L R K Y A D 0 I V S M C E I M 0 K D N M 0 P 1008
3023 CTTGTTTCGATGCTGGCGAACAAACAAGTGTACAACTACGACAAAGGTTCCAATTGGACTTATCAGAAAAAGAAGTTGATGACTTCGTAGAAAATTTCTT 3122
1009 C F D A G E 0 T S V 0 L R 0 R F 0 L D L S E K E V D D F V E N F L 1041
3123 GATAGGTAAATCTTTGGGTAGTATTTACACCAGAATATACGACCAATTTCAACTTATTACACAGGGTATATAGCTGAGAAGGAAAATAGCTGTGACAG 3222
1042 I G K S L G S I Y T R I Y D 0 F 0 L I T 0 G I Y S 1066
3223 AACTGGAAAAACAATTTGCAAATGTCCGGAGAACAAAAAAATTGGAATTTThGTAAAAGGAATATACATATATTATTTATTGCCGAGAATAATAGAGCA 3322
3323 GCTGACTCAGAAAAAGCAAGGTAAAAGAATGAGAGTAAAATAATATGTGGTTAATTAACCATACATATAAATTATTATCTTATTTTCTGCGTAAAGCGT 3422
3423 CAAACCGTTTCTTCAACTCATCTAGTTCATCATTTTCTTGCTCCTTCTTAGTCTTTCTTTTTGTAGTTTTCTTTTCTGATTGTTTCTTTTCGATCACTTC 3522
3523 CTTTTTGATATCTTTCGGAATCTTGAGCTCGTTCTTGATATTTTCACTATTCTGCCTAGGCTTTTTAACAGTGATAGGGTGTTTAGCATCTGC 3615
Fig. 4. Nucleotide and deduced amino acid sequence of PIKI. A set of putative TATA boxes and polyadenylation signals are in bold. Consensus
sequences for the PRE, TGAAACA, and the SWI4-SWI6 cell cycle box (SCB), CACGAAA, in the 5' untranslated region are indicated. The
underlined amino acid sequences are the lipid kinase motif (see text and Figure 5). The EMBL Data Library accession number for the sequence
reported in this paper is X76058.
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PIML: (795)ArIGDAFAAYIQtPM.IWN.KE....KVDVWVKWLITSA
p110: (801) E1ILTLIRIEN. IWJ2....GDLRPYGCLSIGD
VP34: (623) E MIADtQULVVIISIM.kELLNE ... .NVDLKTPYKIIA'
TM: (2127) IN3HFDIFSLVMMLFGLV.N1L141AEaRRHIDIQ2YPAIPLSP
T1M: (2123) INHEDIpSLVMMELGLV.NnmIQSEaFKRHIDIQQYPAIPiSP
23 30 37
+ -+ -+ +
NTGLVETITWMVHSIKK- (45) -SSLAAYSVICYIZVNtFlNIGNI.NEG;iVSHIEG
CVGLIEVVRHTIM2IQC- (36-)-RSC;YCVTFIWIINMI .KIXO;L[I
QEGIEFIPN.DTLASILS- (31) -KSCAGYCVITYIIGvt3ELNLV.TPDQJFFRA
KSGGWVPNSDTFHVLIR- (70)-MIVVMIllmA
KSGLJLGVPNSDTFHVLIR- (70) -RS-AVGY SNPNI LDRI II
Fig. 5. The lipid kinase motif. This motif is found in the carboxy-
termini of PIKI (1066 amino acids), the plO catalytic subunit of
bovine PI 3-kinase (1068 amino acids), VPS34 (875 amino acids),
TOR2 (2474 amino acids) and TOR1 (2470 amino acids). The position
of the first residue in the motif within the complete sequence is
indicated in parentheses. Residues present in all the sequences are
shown in bold. Note that many substitutions are highly conservative.
wt high copy
C N C N
P 1-3-P
P 1-4-P
Fig. 6. Overexpression of a PI 4-kinase activity in yeast cells
containing PIKI in a multicopy plasmid. The PI kinase activity present
in the cytosolic (C) and nuclear (N) fractions of yeast cells containing
a single copy of PIKJ (wt) or the cloned gene on a multicopy plasmid
(pGBI) (high copy), was assayed as described in the text. Cell-
equivalent amounts of cytosolic (12 pg) and nuclear (4 yg) proteins
were assayed. Plus and minus signs indicate the presence or absence
of 1 mM adenosine in the assay. The apparent reduction in the
intensity of the PI-3-P spot in the adenosine-treated sample from
overproducing nuclei was not reproducible. It should also be noted that
although approximately equal PI 3-kinase and PI 4-kinase activities are
detected in total yeast extracts (Auger et al., 1989), most of the PI
3-kinase activity localizes to the membrane fraction (Schu et al., 1993)
and is therefore not present in our assay. The Rf for PI-3-P and PI-4-P
in this TLC system is indicated.
an increased capacity to phosphorylate PI and the increase
in activity could be accounted for exclusively by an increase
in nucleus-associated activity (Figure 6). In three independent
experiments, the increase in PI kinase activity observed in
nuclear fractions was 2.6-, 1.5- and 3.2-fold, compared with
a non-overproduicing strain and as measured by densitometry
of suitably exposed autoradiograms. In the TLC system used,
the overproduced product had the Rf of PI4-phosphate
(PI-4-P) (see Materials and methods) (Walsh et al., 1991;
Schu et al., 1993). PI 4-kinase activity was also detected
in cytosolic fractions but this activity was not increased by
overexpression of PIK1.
To obtain further evidence that the increased, nuclear PI
4-kinase activity was encoded by PIK1, we determined
whether the increased activity was lost at high temperature
in nuclei overexpressing the temperature-sensitive pikl-12
allele. A plasmid-bome pikl-12 allele supports growth at
23 and 300C but not at 370C in strains containing a
chromosomal disruption of PIKI (see below). Strain
BJ2168/pCF12 containing the pikl-12 allele on a high copy
number plasmid was grown at the permissive temperature;
Fig. 7. The nuclear fraction of cells expressing pikl-12 contains
temperature-sensitive PI 4-kinase activity. The nuclear fraction of cells
containing wild type PIKJ (+) or the temperature-sensitive pikl-12
allele (-) on a high copy number plasmid were assayed for PI
4-kinase activity at 23, 30 and 37°C (37). Four micrograms of nuclear
protein were used in each assay. The Rf for PI-3-P and PI-4-P in this
TLC system is indicated.
nuclei were isolated, equilibrated to permissive (23 and
300C) and non-permissive (370C) temperatures, and assayed
for PI kinase activity at the same temperatures. In two
independent experiments, the PI 4-kinase activity of the
pikl-12 nuclei was reduced by 2.3- and 3.7-fold at 370C
but was not significantly affected when the assay was
performed at the two permissive temperatures, compared
with nuclei from a strain (BJ2168/pGBl) overproducing wild
type PIKI (Figure 7). Contrary to the nuclear PI 4-kinase
activity of strain BJ2168/pCF12, the cytosolic PI 4-kinase
activity of the same strain was neither overexpressed or
temperature-sensitive (data not shown). Thus, PIKJ encodes
a nucleus-associated PI 4-kinase.
PI 4-kinases have been classified biochemically into two
different types based on sensitivity to adenosine. Type II PI
4-kinase is sensitive to adenosine, whereas typem is resistant
(type I PI kinase is PI 3-kinase) (Carpenter and Cantley,
1990). We found that adenosine at 1 mM, more than 50 times
the described Ki for type II PI 4-kinases (Endemann et al.,
1987), reduced the amount of phosphorylated inositol
produced by the nuclear fraction by 40-60%, as measured
by film densitometry in two independent experiments (Figure
6). This partial inhibition may reflect two different PI
4-kinases (types II and m) in the nuclear fraction. The
cytosolic PI 4-kinase was insensitive to inhibition by 1 mM
adenosine.
PI 4-kinases described so far are stimulated by Triton
X-100 at concentrations above its critical micellar
concentration (Endemann et al., 1987 and references
therein). We could not interpret the results of adding the
detergent to our assays because we observed that in our
reactions the endogenous inositol present in the nuclear
membranes was also used as substrate, and adding detergent
removed it, producing an inhibitory effect that obscured a
possible activation.
PIK1 expression and function
The presence of PREs in the promoter region of PIKI
suggested that PIKI might play a role in some process
controlled by a-factor. We tested whether PIKI in increased
dosage affected the sensitivity of a cells to the growth
inhibitory effect of a-factor, as measured by a halo assay.
FM1-5d/pGBI cells (disrupted for the chromosomal PIKI
gene so as to maintain the high copy number plasmid pGBl
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independently of the growth medium) showed an unchanged
or very slightly increased sensitivity to a-factor compared
with an isogenic strain (JK9-3da) containing a single copy
ofPIK] (data not shown). Thus, as measured by this assay,
overexpression of the gene has little to no effect on sensitivity
to ae-factor.
To investigate whether the SCBs found in the promoter
region of PIK] (Figure 4) conferred GI-specific
transcription, total RNA was prepared from cells
synchronized using the temperature-sensitive mutation
cdc15-2 in strain RH210-3c. The PIK] transcript was
followed during two cell cycles after the release of a
temperature block. Northern blots did not reveal any
significant increase in PIKI transcription at GI, although
the transcripts for GI and G2 cyclins showed normal
periodicity in the RNA preparations from the synchronized
cells (data not shown). Perhaps the PREs and the SCBs
function together as a hybrid promoter, conferring increased
expression of PIKI at G1 only in the presence of a-factor,
i.e. the PIK] promoter may confer GI specificity on
pheromone-induced transcription.
The antibiotic neomycin binds to PI lipids and has been
proposed to inhibit signal transduction in platelets by keeping
such lipids inaccessible to phosphodiesterases (Tysnes et al.,
1988). It is conceivable that increased synthesis of PI-4-P
through overexpression of PIKI could increase the flow
through the pathway and thereby elevate the minimum
inhibitory concentration for neomycin. The growth of
isogenic strains with and without PIK] in high copy number
plasmids was monitored on YPD plates containing increasing
concentrations of the antibiotic. All strains displayed the same
sensitivity, being completely inhibited by 6 mg/ml of
neomycin. Apparently, increased dosage of PIK1 does not
alter the sensitivity of yeast cells to neomycin.
PIK1 conditional mutants are defective in cytokinesis
Because null alleles of PIKI are lethal, conditional mutants
were isolated to facilitate the analysis of PIK1 function.
Conditional alleles were obtained by chemical mutagenesis
of plasmid-borne PIK] (pGB2, see Materials and methods).
Of eight independent temperature-sensitive mutants isolated
so far, pikl-12 will be described in detail here, although all
seem to have similar properties. A haploid strain with a
disrupted chromosomal copy of PIKI and pikl-12 on a
multicopy vector (FMI-5d/pCF12) stops growing within 2
h of shifting from the permissive (23 or 30°C) to the non-
permissive temperature (37°C); growth was measured as an
increase in OD6W. Microscopic examination of the arrested
cells revealed a cytokinesis defect, since most cells appeared
as pairs with fully separated nuclei. Also apparent but less
abundant were cell triplets, again with fully segregated nuclei
(Figure 8). Flow cytometry (FACS analysis) corroborated
that most cells had a 2n or higher DNA content (Figure 8).
The cytokinesis defect was also observed at the permissive
temperature, although at 23°C the proportion of cell triplets
was significantly lower; at 23°C, the mutants grew only
slightly slower than the wild type. The limited function of
the pikl-12 allele is enough to allow cells to proliferate at
the permissive temperature, but it is apparently not enough
to allow the cells to cope with the added stress of high
temperature or, alternatively, the pikl-12 protein loses
function completely at 37°C. The PI 4-kinase activity of
pikl-12 is severely reduced at 37°C (see above).
By analogy with the phosphoinositide signal transduction
pathway of higher eukaryotes, PKC in yeast may act
downstream of PI 4-kinase. Thus, strains defective in PI
4-kinase could have phenotypic characteristics in common
with strains defective in PKC. Temperature-sensitive alleles
of PKC], which encodes a yeast PKC, confer a cell wall
defect and a terminal phenotype of cells with small buds and
undivided nuclei containing 2n DNA. This temperature-
sensitive phenotype, can be suppressed by increasing the
osmolarity or the Ca2+ concentration of the growth medium
(Levin and Barlett-Heubusch, 1992; Paravicini et al., 1992).
We tested the ability ofpikl-12 strains and of spores carrying
the pikl:.:ADE2-1 allele to grow on YPD plates supplemented
with 1 M sorbitol, 100 mM CaCl2 or 100 mM MgCl2. As
observed with PKC1 mutants, sorbitol and CaCl2, but not
MgCl2, suppressed the temperature-sensitive growth defect
of pikl-12 (data not shown). The pikl]::ADE2-1 null allele
was not suppressed by any of the supplements. Furthermore,
unlike the rapid lysis observed in pkcl mutants, pikl-12
mutants were still viable after 6 h at the restrictive
temperature. When cells were returned to 23°C and plated
on YPD, - 50% of the cells counted in a Neubauer chamber
gave rise to colonies.
A PIK1 disruption is not complemented by other
known or presumed yeast PI kinases
Because PIKI is structurally related to the presumed PI
kinases TOR1 and TOR2, and to the PI 3-kinase VPS34
(Figure 5), we tested whether the disruption allele of PIK]
in strain FM1 could be complemented by TORI (pPW20),
TOR2 (pJK3-3) or VPS34 (pMD21) provided on a high copy
number vector. When diploid FM1 cells (pik1:.ADE2-1/
PIK]) containing pPW20, pJK3-3 or pMD21 were
sporulated and dissected (14 tetrads from each transformant)
only two viable spores, both carrying the non-disrupted allele
of PIK], were recovered from each tetrad; in each dissection,
the plasmid marker (URA3) was detected in the viable
segregants. Thus, neither TOR], TOR2 nor VPS34 in high
dosage can supply the function(s) missing in a PIK]
disruption strain.
Discussion
We have cloned a yeast gene, PIK1, encoding a nucleus-
associated PI 4-kinase. This study presents the first sequence
of a PI 4-kinase and the first direct evidence that a PI 4-kinase
is essential for growth. The carboxy-terminus of PIK1
contains a lipid kinase motif previously found in the carboxy-
termini of the p110 catalytic subunit of bovine PI 3-kinase,
the yeast PI 3-kinase VPS34, and the two putative PI kinases
TORI and TOR2 (Hiles et al., 1992; Kunz et al., 1993;
Schu et al., 1993; Helliwell et al., 1994), indicating that this
is a general motif found in different types of PI kinases.
Disruption and conditional alleles suggest that PIK] is
required for cytokinesis.
Disruptions of the PIKI gene are lethal. This result
indicates that there are no other PI 4-kinases that can
substitute for PIK1, although several seemingly different PI
4-kinase activities have been described in S.cerevisiae.
Several membrane-bound forms have been described and the
molecular sizes of two of these enzymes have been estimated
to be 45 and 55 kDa (Buxeda et al., 1991; Nickels et al.,
1992; McKenzie and Carman, 1993). A partially soluble
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Fig. 8. Temperature-sensitive pikl-12 mutant has a cytokinesis defect. FMI-5d/pGB2 (wild type) and FMI-5d/pCF12 (pikl-12) cells were grown in
SD-Leu medium at 23 or 37°C. Samples were taken after 6 h and processed for FACS analysis as described in Materials and methods. A fraction of
each sample was examined with Nomarski optics (left panel) and for staining with the DNA-specific fluorescent stain propidium iodide (middle
panel). The results of the FACS analysis (right panel) are illustrated as the number of cells (y-axis) with a certain DNA content (x-axis). The two
peaks in the wild type sample correspond to ln (left peak) and 2n (right peak) DNA contents. The major peak in pikl-12 at 37°C presumably
represents 3n DNA content. The bar within the dark rectangle in the upper left micrograph represents 10 /m.
activity of 120 kDa has also been described (Flanagan and
Thorner, 1992). Based solely on the published sizes, this
last enzyme is the best candidate for the product of the PIKI
gene. However, overexpression of PIKI or tagging of PIKI
with a temperature-sensitive mutation causes a corresponding
change only in nucleus-associated PI 4-kinase activity;
cytosolic activity remains unaffected (Figures 6 and 7). This
could indicate that there are two enzymes with similar sizes
but different cellular locations, in agreement with the
different sensitivities toward inhibition by adenosine
displayed by our nuclear and cytosolic fractions.
Null mutants of PIKI are inviable but some spores
carrying a disruption allele do germinate, only to arrest as
cells with a single large bud. Cells carrying an allele ofPIK]
that confers temperature-sensitive growth display a similar
morphology of cells with large buds and fully divided nuclei
(Figure 8). This suggests that the product of PIKI (PI-4-P)
plays a role in controlling cytokinesis. However, even at the
permissive temperature, the temperature-sensitive mutants
still accumulate unseparated cells (Figure 8). The
temperature-sensitive mutants arrest growth only at 370C
because the cytokinesis defect is more severe at this
temperature or because, at the higher temperature, PI-4-P
becomes limiting for an essential process unrelated to
cytokinesis.
Mutations in another presumed phosphoinositide signalling
pathway component in S.cerevisiae, the PKC encoded by
PKC], affect cell wall metabolism. Temperature-sensitive
PKCJ mutants display cell cycle-specific, rapid lysis at
restrictive temperature, PKCJ conditional alleles are
suppressed by high osmolarity or an elevated Ca2+
concentration but null alleles are suppressed only by high
osmolarity (Levin and Barlett-Heubusch, 1992; Paravicini
et al., 1992). Furthermore, overexpression of an endogenous
PKC in Schizosaccharomyces pombe causes a cytokinesis
defect (Mazzei et al., 1993). Our observations are
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reminiscent of, but not identical to, the above mentioned.
Conditional PIK] mutations confer a growth defect that is
suppressed by 1 M sorbitol or 100 mM Ca2+. However,
the lethality caused by PIK] disruptions is not suppressed
by elevated concentrations of sorbitol or Ca2+ and the
pikl-12 mutant does not lose viability (lyse) rapidly at the
restrictive temperature. Suppression of the PIKI conditional
allele, but not the null allele, by high osmolarity or Ca2+
can be explained as follows. The two different supplements
may be specifically suppressing the conditional allele by
different mechanisms. High osmolarity could directly
stabilize the mutated enzyme, as previously suggested for
the suppression of missense mutations in nutritional genes
(Hawthorne and Friis, 1964). The finding that high
osmolarity does not suppress a null mutation suggests that
the suppression is not of a cell wall defect. Increased Ca2+
could act as an 'effector' to stimulate the enzymatic activity
of the mutated PIKI or the activity of a compensating
function; Ca2+ normally stimulates a number of enzymes
that act on or are influenced by phospholipids (e.g.
phospholipase A2, phospholipase C and PKC). Because the
normal activation of certain enzymes by Ca2+ is specific for
this ion, this model also accounts for why Mg2+ does not
suppress a PIK1 conditional mutation.
What are the cellular components downstream of PIK1?
Obvious possibilities include the PI-specific phospholipase
C (PLC 1) and PKC 1. As discussed above, the phenotypes
ofPKC] and PIK] mutants partly overlap. The same is true
for PLC] and PIK] mutants as both exhibit a cytokinesis
defect (Flick and Thorner, 1993; Payne and Fitzgerald-
Hayes, 1993; Yoko-o et al., 1993). Considering the
cytokinesis defect observed in PIKI mutants, another
candidate for a downstream component is the actin
cytoskeleton. Yeast spores with a disrupted actin gene,
AC72, arrest as single cells with a large bud and diploid cells
with only one functional copy of AC72 show an increase
in the number of cells with multiple large buds, each having
its own nucleus (Schwob and Martin, 1992). These are the
same phenotypes described here for null and conditional
mutations of PIK1. Furthermore, phosphorylated
phosphoinositides have been implicated in actin
rearrangement. The function of actin binding proteins is
known to be modulated in vitro by PI-4,5-P2. The yeast
capping protein, which binds to the growing end of actin
filaments, is prevented from doing so by micromolar
concentrations of PI-4,5-P2 (Amatruda and Cooper, 1992)
and profilin, an essential protein in yeast which participates
in the remodelling of the actin cytoskeleton, is also known
to be dissociated from actin by PI-4,5-P2 (Lassing and
Lindberg, 1985; Magdolen et al., 1988). In neutrophils and
fibroblasts, PI-3,4,5-P3 is believed to modulate
rearrangement of the actin cytoskeleton (Eberle et al., 1990;
Arcaro and Wymann, 1993; Wymann and Arcaro, 1994).
Thus, a strain defective in PIK1 may produce less PI-4,5-P2
or PI-3,4,5-P3, which could then hinder actin cytoskeleton
remodelling necessary for cytokinesis.
PIK1 was identified by screening a yeast expression library
with the QE5 monoclonal antibody, raised against a human
nuclear pore component (McMorrow et al., 1994). Although
QE5 recognizes a yeast nuclear protein by Western blotting,
efforts to immunolocalize the protein in intact yeast cells
using the monoclonal antibody have failed to give a signal
in any cellular compartment, perhaps because the epitope
is inaccessible under conditions which preserve nuclear
integrity. Thus, because the nuclear envelope constitutes a
substantial fraction of the yeast endoplasmic reticulum, we
cannot at present rigorously state that the enzyme is
exclusively nuclear. Polyclonal antibodies may be required
to determine more precisely the location of PIK1. The
observed association of PIKI with nuclei is in full agreement
with observations of a nuclear phosphoinositide cycle distinct
from the better known plasma membrane cycle (Divecha
et al., 1991, reviewed in Divecha et al., 1993; Irvine and
Divecha, 1992; Payrastre et al., 1992). If PIK1 is indeed
a nuclear pore component (Pante and Aebi, 1993), it could
provide a mechanism to connect transport across the nuclear
envelope to other cellular processes via inositol signalling.
A nuclear location for PIKI could, furthermore, link
completion of nuclear division with cytokinesis.
While this manuscript was in preparation, Flanagan et al.
(1993) presented the cloning and disruption of PIK1. They
cloned PIK] using DNA probes derived from the sequence
of a purified PI 4-kinase and presented evidence that PIKI
is a soluble enzyme involved in the pheromone response
(Flanagan and Thorner, 1992; Flanagan et al., 1993). Two
significant differences between our findings and those studies
are the subcellular distribution of the PI 4-kinase activity
and the role of the enzyme in pheromone response. The
apparent difference in localization could be attributed to
different methods of cellular fractionation. Our method,
consisting of manual douncing of spheroplasts followed by
pelleting of nuclei onto a sucrose cushion, was designed to
generate intact nuclei (Hurt et al., 1988; Garcia-Bustos
et al., 1991b). The method used by Flanagan and Thorner
(1992), consisting of breaking cells by vigorous mixing with
beads (BeadbeaterTm) followed by extensive high speed
centrifugation, was designed to produce a rich supernatant
fraction. This method may break nuclei and release what
might otherwise be a particulate activity; the finding by
Flanagan and Thorner (1992) that -40% of their activity
was associated with the particulate fraction may indeed
reflect incomplete nuclear breakage. We cannot as of yet
explain why we did not detect a reproducible enhanced
sensitivity to a-factor by strains overproducing PIKI
(Flanagan et al., 1993), but our results do not exclude a role
for PIKI in the pheromone response.
Materials and methods
Strains, plasmids and culture media
Escherichia coli strains Y1090, used to propagate X phages and DH5ac,
used to obtain DNA for sequencing, were as described (Sambrook et al.,
1989). Strain MHI (araD139 AlacX74 galE galK hsr rpsL) was sometimes
used to isolate recombinant plasmids and strain MH4 (AlacX74 galE galK
hsr rpsL leuB600) was used to test complementation with the yeast LEU2
gene. E. coli strains were routinely grown on LB or M63 media (Sambrook
et al., 1989) with the antibiotics appropriate for plasmid maintenance.
Saccharomyces cerevisiae strain JK9-3d (leu2-3,112 ura3-52 trpl his4
GAL' rnel HMLa) or its ade2A/ade2A homozygous diploid derivative
were used for all genetic manipulations. The protease-deficient strain BJ2168(a/cs leu2/leu2 trpl/trpl ura3-52/ura3-52 prbl-1122/prbl -1122
pep4-3/pep4-3 prcl-407/prcl-407) (provided by E.Jones) was used for cell
fractionation studies. Synchronized cultures were prepared from strain
RH210-3c (ade2-1 bar] cdc15-2 his4 trpl) (provided by H.Reizman), which
arrests in G2 when shifted to the non-permissive temperature.
Transformation, gene disruption, sporulation and tetrad dissection were done
following standard procedures (Guthrie and Fink, 1991). Yeast cells were
grown on either rich medium, YPD, or synthetic minimal medium, SD,
with the appropriate nutrient supplements. Growth media and sporulation
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media were prepared as described (Guthrie and Fink, 1991). The following
shuttle plasmids were used: pSEY18 (URA3 2c ampr) (provided by
S.Emr), YEplacl8l (LEU2 2p ampr), YEplacl95 (URA3 2s amp') and
YIplac21l (URA3 amp'). The Y-plac series of plasmids has been
previously described (Gietz and Sugino, 1988). pGBl, the original full-
length PIKI clone, is pSEY18 carrying a 15 kbp insert. pGB2 is YEplacl81
with PIKI on a SacI fragment and pCF12 is the same construct with the
pikl-12s mutant allele. pGB3 is YEplacl81 containing PIK] in an
SphI-SacI fragment (Figure 3B). pPW20 is pSEY18 carrying TOR1(Helliwell et al., 1994) and pJK3-3 is the same vector with TOR2 (Kunz
et al., 1993). pMD21 is YEplacl95 with VPS34 in a 4 kbp KpnI-PstI
fragment (provided by M.Deuter-Reinhard).
Cloning, sequencing and physical mapping of PIK1
All procedures used were standard techniques previously described(Sambrook et al, 1989). The mouse monoclonal antibody QE5 raised against
nuclear envelopes from HeLa cells (McMorrow et al., 1994) was used to
screen a yeast genomic Xgtl 1 expression library, with an average insert
size of 2.3 kbp (provided by M.Altmann) (Altmann et al., 1987). Plaques
expressing the QE5 antigen were visualized using a peroxidase-conjugated
rabbit anti-mouse antibody (Dakkopats, Denmark) and chemiluminescence
detection (Amersham), as recommended by the manufacturer. Two out of
2 x 105 plaques screened gave a positive signal after four rounds of plaque
purification. Restriction analysis of the corresponding phages revealed that
the inserts were - 500 and 300 bp in size and that both contained a Bgll
site. DNA inserts from positive phages were recovered by PCR using
standard techniques (Innis et al., 1990). An isolated phage plaque was used
as a template and custom oligonucleotides, complementary to the sequences
flanking the EcoRI cloning site in Xgtl 1, were used as primers. Sequence
analysis of the PCR fragments indicated that the inserts of the two phages
were overlapping sequences.
The full-length PIK1 gene was obtained by using the - 500 bp phage
insert to probe a yeast genomic library constructed in the pSEY18 vector,
with an average insert size of 12 kbp (Helliwell et al., 1994). Out of -6000
colonies screened, 15 positives were initially picked but only two were
retained after four rounds of replating. Both isolates had inserts of - 15
kbp with identical restriction patterns. One, named pGBl, was chosen for
further analysis.
For sequencing, restriction fragments were cloned into plasmid
pGEM7Zf(+) and sets of nested deletions were produced by exonuclease
Ill digestion using the Erase-a-Base system (Promega), according to the
manufacturer. Sequence gaps not accessible by the deletions were closed
using custom oligonucleotides as primers. DNA sequencing was performed
by the dideoxy chain termination method, using the T7 sequencing system
from Pharmacia. Computer-assisted assembly and manipulation of the
sequences was done using the GCG set of programs (Genetic Computer
Group Inc.). Homology searches were conducted using the BLASTP and
FASTA programs (Altschul et al., 1990).
PIK] was mapped physically by using the - 500 bp insert present in one
of the original Xgtl 1 clones to probe a membrane containing S. cerevisiae
chromosomes separated by pulsed-field electrophoresis in a 1% agarose gelin a Rotaphor apparatus (Biometra). High resolution mapping was
accomplished by probing a set of filters containing ordered X and cosmid
clones accounting for 99% of the S.cerevisiae genome (kindly provided by
L.Riles, Washington University) (Riles et al., 1993).
Isolation of conditional alleles of PIK1
Procedures for chemical mutagenesis and identification of mutated plasmids
by the plasmid shuffle method have been described previously (Sikorski
and Boeke, 1991). Briefly, plasmid pGB2 (LEU2) was treated in vitro for
various times with 1 M hydroxylamine. The level of mutagenesis was
assessed by testing the plasmids for complementation of the leucine
auxotrophy of E.coli strain MH4. Plasmid preparations in which 3% of
the LEU2 genes had been inactivated were used to transform S. cerevisiae
strain FMl-5d/pGBl (URA3). Leu+transformants which were able to lose
the pGB1plasmid at 23°C but not at 37°C were identified by plating on5-fluoroorotic acid-containing medium. Eight independent, recessive,
plasmid-linked, temperature-sensitive mutants were obtained. The
temperature-sensitive phenotype was expressed on both minimal and rich
medium.
Cell fractionation and Pi kinase assay
Strain BJ2168 was grown in SD medium to an OD6W of 0.4-0.6,
spheroplasted, lysed by manual douncing in a hypotonic medium containing
protease inhibitors and fractionated as described to purify yeast nuclei (Hurt
et al., 1988; Garcia-Bustos et al., 1991b). The 100 000 g cytosolic fraction
was obtained by centrifuging the postnuclear supemnatant for 1 hat 106 000 g
(average) in a TL-100 tabletop ultracentrifuge (Beckman). The PI kinase
activity present in the different cellular fractions was assayed essentially
as described (Whitman et al., 1985), with the following modifications.
Sonicated PI micelles at 0.25 mg/nil were used as substrate and the reactions
were started by adding [.y-32P]ATP (3 Ci/mmol) to a final concentration
of 60 ,sM. Adenosine was added where appropriate to a final concentration
of 1 mM. Incubations were stopped after 10 min at 30°C and the lipid
reaction products were separated by TLC in the presence of boric acid,
using Silicagel 60 plates (E.Merck) previously coated with
trans-1,2-diaminocyclohexane-N,N,N,N,-tetaacetic acid as described (Walsh
et al., 1991). Cellular fractions assayed for PI kinase activity at different
temperatures were pre-incubated for 2 min at the desired temperature (23,
30 and 37'C) and maintained at the same temperature for the duration (10
min) of the assay; otherwise all steps were the same as described above.
Only two major phosphorylated lipid products are generated in the assay
described above, PI-3-phosphate (PI-3-P) and PI4-phosphate (PI4P) (Auger
et al., 1989). Their respective identities were established by analysing in
parallel extracts from cells producing PI4-P but lacking detectable PI
3-kinase activity (a disruption mutant of VPS34 provided by S.Emr) (Schu
etal., 1993).
Miscellaneous methods
To probe for PIKJ transcripts, total yeast RNA was prepared and analysed
by Northern blotting as described (Sambrook et a., 1989). The 32P-labeled
1.2 kbp Bgfll fragment from the 5' end of PIK] (Figure 3) was used as
a probe.
Standard methods were used for immunological detection of proteins
separated in SDS-polyacrylamide gels and transferred to PVDF membranes
(Millipore). In all cases, detection was accomplished with horseradish
peroxidase-conjugated secondary antibodies and chemiluminescence
detection.
Sensitivity to a-factor was tested on plates containing 20 ml of2% agar
YPD, which were overlayed with 4 ml of 0.7% agar YPD containing 50 I1
of overnight cultures of the appropriate yeast strains adjusted to an OD6W
of 3.0. ca-factor (provided by E.Kubler) was serially diluted and 10 1d of
each dilution were spotted onto sterile filter disks placed onto the soft agar
overlay. The plates were incubated at 30'C for 24 h and the diameter of
the inhibition zones around the paper disks was measured.
Flow cytometry (FACS analysis) was performed on 300 p1 of cells chilled
on ice, sonicated for 2 min in a water bath sonicator and diluted with 700
i1 cold absolute ethanol. After shaking overnight at 4°C the cells were
centrifuged briefly, washed once in 50 mM sodium citrate pH 7.4, and
resuspended in 500 1 50 mM sodium citrate pH 7.4 containing RNase A
at 0.25 mg/ml. After incubating 1 h at 37'C, 500 ,ul of 50 mM sodium
citrate and 16 1sg/ml propidium iodide were added. A Becton-Dickinson
FACScan machine was used to measure fluorescence; 10 000 events were
analysed for each strain.
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